BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38578209)

  • 1. Long-term Mammography Screening Trends and Predictors of Return to Screening after the COVID-19 Pandemic: Results from a Statewide Registry.
    Sprague BL; Nowak SA; Ahern TP; Herschorn SD; Kaufman PA; Odde C; Perry H; Sowden MM; Vacek PM; Weaver DL
    Radiol Imaging Cancer; 2024 May; 6(3):e230161. PubMed ID: 38578209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
    Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
    JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Registry-based study of trends in breast cancer screening mammography before and after the 2009 U.S. Preventive Services Task Force recommendations.
    Sprague BL; Bolton KC; Mace JL; Herschorn SD; James TA; Vacek PM; Weaver DL; Geller BM
    Radiology; 2014 Feb; 270(2):354-61. PubMed ID: 24072778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in Mammography Use by Women's Characteristics During the First 5 Months of the COVID-19 Pandemic.
    Sprague BL; Lowry KP; Miglioretti DL; Alsheik N; Bowles EJA; Tosteson ANA; Rauscher G; Herschorn SD; Lee JM; Trentham-Dietz A; Weaver DL; Stout NK; Kerlikowske K
    J Natl Cancer Inst; 2021 Sep; 113(9):1161-1167. PubMed ID: 33778894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of a Risk-Based Approach for Triaging Mammography Examinations During Periods of Reduced Capacity.
    Miglioretti DL; Bissell MCS; Kerlikowske K; Buist DSM; Cummings SR; Henderson LM; Onega T; O'Meara ES; Rauscher GH; Sprague BL; Tosteson ANA; Wernli KJ; Lee JM; Lee CI
    JAMA Netw Open; 2021 Mar; 4(3):e211974. PubMed ID: 33764423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk.
    Lee JM; Arao RF; Sprague BL; Kerlikowske K; Lehman CD; Smith RA; Henderson LM; Rauscher GH; Miglioretti DL
    JAMA Intern Med; 2019 May; 179(5):658-667. PubMed ID: 30882843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast and Lung Cancer Screening Among Medicare Enrollees During the COVID-19 Pandemic.
    Doan C; Li S; Goodwin JS
    JAMA Netw Open; 2023 Feb; 6(2):e2255589. PubMed ID: 36735262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multilevel Factors Associated With Time to Biopsy After Abnormal Screening Mammography Results by Race and Ethnicity.
    Lawson MB; Bissell MCS; Miglioretti DL; Eavey J; Chapman CH; Mandelblatt JS; Onega T; Henderson LM; Rauscher GH; Kerlikowske K; Sprague BL; Bowles EJA; Gard CC; Parsian S; Lee CI
    JAMA Oncol; 2022 Aug; 8(8):1115-1126. PubMed ID: 35737381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in breast cancer risk distribution among Vermont women using screening mammography.
    Bolton KC; Mace JL; Vacek PM; Herschorn SD; James TA; Tice JA; Kerlikowske K; Geller BM; Weaver DL; Sprague BL
    J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 24957223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures.
    Nyante SJ; Benefield TS; Kuzmiak CM; Earnhardt K; Pritchard M; Henderson LM
    Cancer; 2021 Jun; 127(12):2111-2121. PubMed ID: 33635541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk.
    Glechner A; Wagner G; Mitus JW; Teufer B; Klerings I; Böck N; Grillich L; Berzaczy D; Helbich TH; Gartlehner G
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD009632. PubMed ID: 36999589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial and socioeconomic inequities in breast cancer screening before and during the COVID-19 pandemic: analysis of two cohorts of women 50 years + .
    Monsivais P; Amiri S; Robison J; Pflugeisen C; Kordas G; Amram O
    Breast Cancer; 2022 Jul; 29(4):740-746. PubMed ID: 35366175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five Consecutive Years of Screening with Digital Breast Tomosynthesis: Outcomes by Screening Year and Round.
    Conant EF; Zuckerman SP; McDonald ES; Weinstein SP; Korhonen KE; Birnbaum JA; Tobey JD; Schnall MD; Hubbard RA
    Radiology; 2020 May; 295(2):285-293. PubMed ID: 32154771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of COVID-19 pandemic on breast cancer screening in a large midwestern United States academic medical center.
    Johnson KJ; O'Connell CP; Waken RJ; Barnes JM
    PLoS One; 2024; 19(5):e0303280. PubMed ID: 38768115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in breast and prostate cancer screening and diagnostic procedures during the COVID-19 pandemic in central Massachusetts.
    Epstein MM; Sundaresan D; Fair M; Fouayzi H; Warner ET; Garber LD; Gurwitz JH; Field TS
    Cancer Causes Control; 2022 Oct; 33(10):1313-1323. PubMed ID: 35933572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cumulative Probability of False-Positive Results After 10 Years of Screening With Digital Breast Tomosynthesis vs Digital Mammography.
    Ho TH; Bissell MCS; Kerlikowske K; Hubbard RA; Sprague BL; Lee CI; Tice JA; Tosteson ANA; Miglioretti DL
    JAMA Netw Open; 2022 Mar; 5(3):e222440. PubMed ID: 35333365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection Rates for Benign and Malignant Diagnoses on Breast Cancer Screening With Digital Breast Tomosynthesis in a Statewide Mammography Registry Study.
    Fujii MH; Herschorn SD; Sowden M; Hotaling EL; Vacek PM; Weaver DL; Sprague BL
    AJR Am J Roentgenol; 2019 Mar; 212(3):706-711. PubMed ID: 30673339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
    Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
    Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Access to and Use of Digital Breast Tomosynthesis Screening by Women's Race/Ethnicity and Socioeconomic Status.
    Lee CI; Zhu W; Onega T; Henderson LM; Kerlikowske K; Sprague BL; Rauscher GH; O'Meara ES; Tosteson ANA; Haas JS; diFlorio-Alexander R; Kaplan C; Miglioretti DL
    JAMA Netw Open; 2021 Feb; 4(2):e2037546. PubMed ID: 33606032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammographic Screening in Routine Practice: Multisite Study of Digital Breast Tomosynthesis and Digital Mammography Screenings.
    Conant EF; Talley MM; Parghi CR; Sheh BC; Liang SY; Pohlman S; Rane A; Jung Y; Stevens LAS; Paulus JK; Alsheik N
    Radiology; 2023 May; 307(3):e221571. PubMed ID: 36916891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.